Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura de Waal

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neurourology and Urodynamics|November 7, 2019
The vaginal microcirculation after prolapse surgeryArnoud W Kastelein, Chantal M Diedrich, Laura de Waal, et al.
International Journal of Cancer|February 17, 2018
Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in human epidermal growth factor receptor 2-positive advanced oesophagogastric cancer: A meta-analysisEmil Ter Veer, Aafke Creemers, Laura de Waal, et al.
Acta Oncologica (Stockholm, Sweden)|September 29, 2018
Continuation of trastuzumab beyond progression in HER2-positive advanced esophagogastric cancer: a meta-analysisEmil Ter Veer, Tom van den Ende, Aafke Creemers, et al.
Cancers|January 16, 2019
The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysisTom van den Ende, Emil Ter Veer, Mélanie Machiels, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neurourology and Urodynamics|November 7, 2019
The vaginal microcirculation after prolapse surgeryArnoud W Kastelein, Chantal M Diedrich, Laura de Waal, et al.
International Journal of Cancer|February 17, 2018
Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in human epidermal growth factor receptor 2-positive advanced oesophagogastric cancer: A meta-analysisEmil Ter Veer, Aafke Creemers, Laura de Waal, et al.
Acta Oncologica (Stockholm, Sweden)|September 29, 2018
Continuation of trastuzumab beyond progression in HER2-positive advanced esophagogastric cancer: a meta-analysisEmil Ter Veer, Tom van den Ende, Aafke Creemers, et al.
Cancers|January 16, 2019
The Efficacy and Safety of (Neo)Adjuvant Therapy for Gastric Cancer: A Network Meta-analysisTom van den Ende, Emil Ter Veer, Mélanie Machiels, et al.
Pageof 1